Kenji Koneri

9101193, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Spatial Proximity Between PD-L1(+) Tumor-Associated Macrophages and CD8(+) T Cells Influences Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma.

Spatial Proximity Between PD-L1(+) Tumor-Associated Macrophages and CD8(+) T Cells Influences Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma.

Journal: Cancers

Published: April 05, 2026

Serum Antioxidant Capacity Predicts Prognosis in Patients with Metastatic Colorectal Cancer: An Original Cohort Study.

Serum Antioxidant Capacity Predicts Prognosis in Patients with Metastatic Colorectal Cancer: An Original Cohort Study.

Journal: Antioxidants (Basel, Switzerland)

Published: March 28, 2026

First- Versus Second- or Subsequent-Line Use of Cyclin-Dependent Kinase 4/6 Inhibitors for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic or Recurrent Breast Cancer: A Multicenter, Retrospective Cohort Study.

First- Versus Second- or Subsequent-Line Use of Cyclin-Dependent Kinase 4/6 Inhibitors for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic or Recurrent Breast Cancer: A Multicenter, Retrospective Cohort Study.

Journal: Medicina (Kaunas, Lithuania)

Published: February 20, 2026

A Case Report of Triple-Negative Breast Cancer with High Ki-67 Expression That Responded to Neoadjuvant Pembrolizumab Therapy

A Case Report of Triple-Negative Breast Cancer with High Ki-67 Expression That Responded to Neoadjuvant Pembrolizumab Therapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

CD44v9 Expression in Pretreatment Biopsies as a Predictor of Chemotherapy Resistance in Gastric Cancer.

CD44v9 Expression in Pretreatment Biopsies as a Predictor of Chemotherapy Resistance in Gastric Cancer.

Journal: Cancers

Published: October 12, 2025

PD-L1(+) tumor-associated macrophages induce CD8(+) T Cell exhaustion in hepatocellular carcinoma.

PD-L1(+) tumor-associated macrophages induce CD8(+) T Cell exhaustion in hepatocellular carcinoma.

Journal: Neoplasia (New York, N.Y.)

Published: August 31, 2025

CD133 Expression in Circulating Tumor Cells as a Prognostic Marker in Colorectal Cancer.

CD133 Expression in Circulating Tumor Cells as a Prognostic Marker in Colorectal Cancer.

Journal: International journal of molecular sciences

Published: March 23, 2025

Fibrinogen-Albumin Ratio: An Independent Recurrence Factor for Colorectal Cancer Stages II and III in a Competing Risk Model.

Fibrinogen-Albumin Ratio: An Independent Recurrence Factor for Colorectal Cancer Stages II and III in a Competing Risk Model.

Journal: Journal of the anus, rectum and colon

Published: January 08, 2025

Reduction of Blood Oxidative Stress Following Colorectal Cancer Resection.

Reduction of Blood Oxidative Stress Following Colorectal Cancer Resection.

Journal: Cancers

Published: September 18, 2024

Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer.

Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer.

Journal: Cancers

Published: March 21, 2024

Short-Term Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Short-Term Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 02, 2024

Mass-forming type 2 autoimmune pancreatitis with upstream dilatation of the main pancreatic duct dilatation: a case report.

Mass-forming type 2 autoimmune pancreatitis with upstream dilatation of the main pancreatic duct dilatation: a case report.

Journal: Journal of medical case reports

Published: December 13, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026